59.61
price down icon2.42%   -1.48
after-market アフターアワーズ: 59.61
loading

Halozyme Therapeutics Inc (HALO) 最新ニュース

pulisher
06:42 AM

WCM Investment Management LLC Decreases Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

06:42 AM
pulisher
04:19 AM

Assetmark Inc. Has $5.33 Million Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

04:19 AM
pulisher
Nov 11, 2024

Needle Free Injectors Market Is Expected To Reach a Revenue Of USD 2,980.9 Million By 2033, At 8.1% CAGR: Dimension Market Research - GlobeNewswire Inc.

Nov 11, 2024
pulisher
Nov 08, 2024

Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Foster & Motley Inc. Makes New $609,000 Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Position Trimmed by Kornitzer Capital Management Inc. KS - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Hanseatic Management Services Inc. Invests $581,000 in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 07, 2024
pulisher
Nov 05, 2024

Halozyme: Looking For More Growth Following Record Q3 Earnings (NASDAQ:HALO) - Seeking Alpha

Nov 05, 2024
pulisher
Nov 05, 2024

Catalyst Capital Advisors LLC Invests $1.94 Million in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Halozyme stock price target, rating held on earnings beat By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

H.C. Wainwright lifts Halozyme stock target, buy rating on strong earnings - Investing.com Canada

Nov 05, 2024
pulisher
Nov 04, 2024

Halozyme Therapeutics (NASDAQ:HALO) Given New $52.00 Price Target at Piper Sandler - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Assenagon Asset Management S.A. Sells 40,070 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Results: Halozyme Therapeutics, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance

Nov 03, 2024
pulisher
Nov 02, 2024

HALO Beats Q3 Earnings & Sales Estimates, Raises '24 View, Stock Up - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

VELA Investment Management LLC Makes New $729,000 Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 02, 2024
pulisher
Nov 02, 2024

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 02, 2024
pulisher
Nov 02, 2024

(HALO) Technical Data - Stock Traders Daily

Nov 02, 2024
pulisher
Nov 01, 2024

Halozyme Announces Record Earnings, Guidance - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings call: Halozyme raises full-year guidance on strong Q3 performance - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Halozyme Therapeutics (NASDAQ:HALO) Shares Gap Up After Analyst Upgrade - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

JMP Securities Raises Halozyme Therapeutics (NASDAQ:HALO) Price Target to $73.00 - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Stephens Investment Management Group LLC Sells 62,174 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Halozyme Therapeutics (HALO) Reports Q3 Earnings: What Key Metrics Have to Say - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Halozyme Therapeutics Inc (HALO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Halozyme Therapeutics Reports Strong Q3 2024 Results - TipRanks

Nov 01, 2024
pulisher
Oct 31, 2024

Halozyme Therapeutics: Q3 Earnings Snapshot - CT Insider

Oct 31, 2024
pulisher
Oct 31, 2024

Halozyme Therapeutics Shares Climb As it Raises FY Outlook - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Halozyme Therapeutics (HALO) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Halozyme Therapeutics, Inc. Revises Earnings Guidance for the Year 2024 - Marketscreener.com

Oct 31, 2024
pulisher
Oct 31, 2024

Congress Asset Management Co. Grows Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Halozyme Therapeutics Q3 2024 Earnings Preview - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Sees Large Increase in Short Interest - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

A Look Ahead: Halozyme Therapeutics's Earnings Forecast - Benzinga

Oct 30, 2024
pulisher
Oct 30, 2024

Halozyme Therapeutics : to Present at Upcoming Investor Conferences - Marketscreener.com

Oct 30, 2024
pulisher
Oct 30, 2024

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Acquired by International Assets Investment Management LLC - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Analysts Set Halozyme Therapeutics, Inc. (NASDAQ:HALO) PT at $60.44 - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Davidson Capital Management Inc. - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Not Many Are Piling Into Halozyme Therapeutics, Inc. (NASDAQ:HALO) Just Yet - Simply Wall St

Oct 29, 2024
pulisher
Oct 28, 2024

Arbor Investment Advisors LLC Takes $1.03 Million Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Oct 28, 2024
pulisher
Oct 27, 2024

Creative Planning Has $2.68 Million Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - Defense World

Oct 27, 2024
pulisher
Oct 27, 2024

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Holdings Boosted by Raymond James & Associates - MarketBeat

Oct 27, 2024
pulisher
Oct 26, 2024

Mount Yale Investment Advisors LLC Purchases New Shares in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Oct 26, 2024
pulisher
Oct 25, 2024

HC Wainwright Reiterates Buy Rating for Halozyme Therapeutics (NASDAQ:HALO) - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Unveiling 12 Analyst Insights On Halozyme Therapeutics - Benzinga

Oct 25, 2024
pulisher
Oct 24, 2024

Halozyme maintains 2024 revenue forecast despite patent revocation By Investing.com - Investing.com Australia

Oct 24, 2024
pulisher
Oct 24, 2024

Moody Aldrich Partners LLC Has $6.33 Million Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Halozyme Therapeutics (HALO) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Halozyme maintains 2024 revenue forecast despite patent revocation - Investing.com

Oct 24, 2024
pulisher
Oct 24, 2024

HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE - Marketscreener.com

Oct 24, 2024
pulisher
Oct 23, 2024

Halozyme to Report Third Quarter 2024 Financial and Operating Results - The Malaysian Reserve

Oct 23, 2024
$20.76
price down icon 4.64%
$80.58
price down icon 1.17%
$43.47
price up icon 1.68%
$400.87
price up icon 0.11%
$193.64
price down icon 5.56%
$106.32
price down icon 2.22%
大文字化:     |  ボリューム (24 時間):